Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine.
Lovell JF, Baik YO, Choi SK, Lee C, Lee JY, Miura K, Huang WC, Park YS, Woo SJ, Seo SH, Kim JO, Song M, Kim CJ, Choi JK, Kim J, Choo EJ, Choi JH.
Lovell JF, et al. Among authors: kim jo, kim cj, kim j.
BMC Med. 2022 Nov 30;20(1):462. doi: 10.1186/s12916-022-02661-1.
BMC Med. 2022.
PMID: 36447243
Free PMC article.
Clinical Trial.